Dimensional Fund Advisors LP Lowers Position in Orthofix Medical Inc. (NASDAQ:OFIX)

Dimensional Fund Advisors LP decreased its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 17.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 281,403 shares of the medical device company's stock after selling 61,239 shares during the period. Dimensional Fund Advisors LP owned approximately 0.75% of Orthofix Medical worth $3,732,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD increased its holdings in Orthofix Medical by 3.9% in the first quarter. Price T Rowe Associates Inc. MD now owns 32,957 shares of the medical device company's stock valued at $479,000 after buying an additional 1,236 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Orthofix Medical by 25.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company's stock worth $125,000 after purchasing an additional 1,919 shares during the last quarter. nVerses Capital LLC purchased a new stake in Orthofix Medical during the second quarter worth $27,000. State Board of Administration of Florida Retirement System boosted its position in Orthofix Medical by 34.7% during the first quarter. State Board of Administration of Florida Retirement System now owns 13,562 shares of the medical device company's stock worth $197,000 after purchasing an additional 3,490 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in Orthofix Medical in the second quarter valued at $64,000. 89.76% of the stock is owned by hedge funds and other institutional investors.

Orthofix Medical Price Performance

Shares of NASDAQ:OFIX traded up $0.58 during midday trading on Friday, hitting $15.58. 153,067 shares of the stock were exchanged, compared to its average volume of 333,282. Orthofix Medical Inc. has a twelve month low of $9.57 and a twelve month high of $17.67. The company has a current ratio of 2.48, a quick ratio of 1.13 and a debt-to-equity ratio of 0.24. The company has a 50 day moving average price of $16.21 and a 200-day moving average price of $14.86. The stock has a market cap of $594.69 million, a P/E ratio of -4.81 and a beta of 1.05.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.30) by ($0.58). Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. The company had revenue of $198.62 million for the quarter, compared to analysts' expectations of $195.75 million. On average, research analysts forecast that Orthofix Medical Inc. will post -2.13 earnings per share for the current year.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.